Search

Shortlist History

1 - 10 of 87 search results

Fully-matching results
Groundbreaking medical research from Tasmania to the world

https://www.utas.edu.au/about/news-and-stories/articles/2024/groundbreaking-medical-research-from-tasmania-to-the-world

11 Apr 2024: Professor Tim Walsh, a world-leader in the fight against antimicrobial resistance (AMR), says Tasmania helped to shape his career and world view. Professor Walsh was the University of Tasmania’s Distinguished Alumni Award winner for 2023 and
Transforming The Makers with the NW community

https://www.utas.edu.au/about/news-and-stories/articles/2024/transforming-the-makers-with-the-nw-community

5 Feb 2024: The North-West can now benefit from a modern centre of ‘making’ that hosts hands-on learning experiences, progresses business ideas, and advances the region’s key industries through specialised technology, training and research. Burnie’s
Fulbright scholars awarded for US study

https://www.utas.edu.au/about/news-and-stories/articles/2024/fulbright-scholars-awarded-for-us-study

14 Feb 2024: Three academics and alumni from the University of Tasmania have been recognised with prestigious Fulbright Scholarships. In areas across climate change communication, artificial intelligence in medicine and contemporary voice, the researchers will be
Securing the future of the Tassie devil looks brighter

https://www.utas.edu.au/about/news-and-stories/articles/2024/securing-the-future-of-the-tassie-devil-looks-brighter

9 May 2024: In good news for the Tasmanian devil, $320,000 of philanthropic funds from Save the Tasmanian Devil Appeal donors has been awarded this year in support of research to secure the endangered species. The donations have been allocated to research across
Saving Tassie’s iconic species

https://www.utas.edu.au/about/news-and-stories/articles/2024/saving-tassies-iconic-species

24 May 2024: Tasmanian devils and emerging researchers benefit from long-term donor passion For pharmacist Roger Tall, encountering Tasmanian devils was a regular part of growing up in Orford on the East Coast of Tasmania. “We frequently sighted devils up and
New collaboration aims to improve the lives of people living with…

https://www.utas.edu.au/about/news-and-stories/articles/2024/new-collaboration-aims-to-improve-the-lives-of-people-living-with-parkinsons-disease

21 Feb 2024: A new collaboration between Tasmanian researchers, clinicians and community groups is aiming to improve the lives of people with Parkinson’s disease. The Tasmania Parkinson’s Project includes the development of a registry of people with
Spa-like shelters offer hope for frogs battling fatal fungal disease

https://www.utas.edu.au/about/news-and-stories/articles/2024/spa-like-shelters-offer-hope-for-frogs-battling-fatal-fungal-disease

28 Jun 2024: An international team of researchers has developed spa-like shelters to help endangered frogs survive chytridiomycosis, a deadly fungal disease that has already wiped out at least six amphibian species in Australia and threatens many more
Guardian dogs safeguard livelihoods and biodiversity

https://www.utas.edu.au/about/news-and-stories/articles/2024/guardian-dogs-safeguard-livelihoods-and-biodiversity

28 Feb 2024: A landmark study has revealed how Livestock Guardian Dogs (LGDs) are changing predator behaviour and supporting conservation efforts in the process. Led by a team of experts from the University of Tasmania, Zoos Victoria, and the University of
Find a faster path

https://www.utas.edu.au/about/news-and-stories/articles/2024/find-a-faster-path

15 May 2024: Business student Annabel Lauder’s plan to follow a career path into marketing started forming when she was 12 years old. “I was always interested in studying marketing and advertising, and so the Bachelor of Business was the avenue to do that,”
Study uncovers consequences of Molnupiravir use to treat COVID-19

https://www.utas.edu.au/about/news-and-stories/articles/2024/study-uncovers-consequences-of-molnupiravir-use-to-treat-covid-20

8 Apr 2024: A collaboration between the University of Tasmania and Royal Hobart Hospital Pathology has revealed the consequences of using Molnupiravir to treat COVID-19. Published in Lancet Microbe, the study investigated how Molnupiravir affects the virus in a